Navigation Links
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Date:5/9/2013

elopment of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen expects similar variability in the future. Amgen develops product candidates internally and through licensing collaborations, partnerships and joint ventures.   Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as Amgen may have believed at the time of entering into such relationship. Also, Amgen or others could identify safety, side effects or manufacturing problems with Amgen's products after they are on the market.  Amgen's business may be impacted by government investigations, litigation and product liability claims.  If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions.  Amgen depends on third parties for a significant portion of its manufacturing capacity for the supply of certain of its current and future products and limits on supply may constrain sales of certain of its current products and product candidate development.

In addition, sales of Amgen's products are affected by the reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015 ... held a press conference in Taipei ... in its new Vaucarrin™ platform, a targeted drug delivery ... This event was part of a joint ... Gold NanoTech Inc. (GNT), showcasing GNT,s latest edible ...
(Date:9/1/2015)... Sept. 1, 2015   Ivenix Inc. , ... management system, closed on a $42M round of ... Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity ... the round. This financing will support the company,s ... Leerink Partners LLC acted as the exclusive placement ...
(Date:9/1/2015)... , Sept. 1, 2015 CytRx Corporation ... development company specializing in oncology, today announced that ... Executive Officer, and David Haen , Vice ... present a corporate overview at two significant investment ... and healthcare industries: the FBR & Co. Second ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4
... - Potential First-in-Class Treatment for Type 2 Diabetes ... Inc., a,biopharmaceutical company focused on the discovery and ... metabolic diseases,announced today that it has dosed the ... clinical trial of MBX-2982, a potential first-in-class treatment,for ...
... 25 ExonHit Therapeutics, a drug,and diagnostic discovery ... 1,study assessing the effects of its lead compound, ... EHT 0202 is a,compound, with a novel mechanism ... and neuronal loss and is currently tested in ...
Cached Medicine Technology:Metabolex Initiates Phase 1 Trial of MBX-2982 2ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 2ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 3ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 4
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer ... its groundbreaking new version of endpoint DLP developed specifically for Mac OS. , In ... more than 100 IT and information security professionals had participated. The beta test done ...
(Date:9/1/2015)... ... September 01, 2015 , ... Agriculture innovation, urban farming, ... of the topics to be discussed at Seedstock’s 4th Annual Sustainable Agriculture Conference ... UC San Diego. , In addition to keynotes Pierre Sleiman, founder and CEO ...
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... chosen as the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine ... and Professor of Biomedical Informatics at Columbia University School of Nursing. A member ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, Indianapolis, ... be attending from across the country. All specialties will be represented. Attendees will ...
(Date:9/1/2015)... ... September 01, 2015 , ... AdvantagePlusCaregivers.com® provides information on ... and what to look for and expect when searching for resources, as well ... in Canoga Park, CA by CEO, Richard Weatherman and Co-Founder Piroska Zalkadi, AdvantagePlusCaregivers.com® ...
Breaking Medicine News(10 mins):Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2
... , RANCHO MIRAGE, Calif. , Jan. 26 ... for emergency and medical supplies to assist relief efforts in ... Center, which is currently engaged in the relief effort through Eisenhower,s ... the donation to Samaritan,s Purse®, a non-profit organization that has worked ...
... Jan. 26 Lutheran World Relief,s first shipment of ... , "Our partners at Church World Service (CWS) have confirmed the ... who need it," says Trevor Knoblich , LWR,s Program Coordinator ... CWS, contained health kits and layettes from LWR, and blankets and ...
... CHICAGO , Jan. 26 After a week of trial ... $1-million insurance policy on January 20, 2010 , to settle a ... the physician,s failure to timely diagnose bladder cancer. , In Russell v. ... Carmen Russell and Daniel Russell, Jr. , the wife and ...
... , SAN FRANCISCO , Jan. ... and quality software and professional services solutions for the ... Quantros RRM™ solution to manage its clinical improvement and ... country,s largest non-profit hospital systems with 22 healthcare facilities ...
... was caught red-handed returning from a tryst with his Argentine ... had met his "soul mate." His choice of words seemed ... with Maria Belen Chapur somehow made his sexual infidelity to ... governor didn,t understand is that most women view emotional infidelity ...
... ... , ... -- February is National Heart Month, and Oldways and the Mediterranean Foods ... the traditions of the Mediterranean region. Thousands of scientific studies (and the American Heart Association!) ...
Cached Medicine News:Health News:Coachella Valley Responds to Haiti Disaster with $1-million in Aid 2Health News:LWR Health Kits, Layettes Arrive in Haiti as Relief Efforts Ramp Up 2Health News:LWR Health Kits, Layettes Arrive in Haiti as Relief Efforts Ramp Up 3Health News:Romanucci & Blandin, LLC, Reaches $1 Million Settlement in Medical Negligence Lawsuit 2Health News:Banner Health Systems Adopts Quantros Regulatory Reporting Management (RRM) to Manage Clinical Quality and Performance Data and Support Improvements in Quality of Care 2Health News:His or hers jealousy? Study offers new explanation for sex differences in jealousy 2Health News:10 Healthy Med Ways to Show Your Heart Some Love 2Health News:10 Healthy Med Ways to Show Your Heart Some Love 3
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
... a high light intensity. Light ... different brightness steps (Halogen 150) ... output can be adapted to ... small diameter scope, etc.). Different ...
Cold light source single outlet....
Cold light source single outlet....
Medicine Products: